ALISON L. HANNAH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALISON L. HANNAH.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALISON L. HANNAH. ALISON L. HANNAH is a Director in NEOGENOMICS INC ($NEO) and a Chief Medical Officer in CytomX Therapeutics, Inc. ($CTMX).
Address: 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS 33913 FL
Companies in which ALISON L. HANNAH is an Insider
CytomX Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of ALISON L. HANNAH: Chief Medical Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 02 2021
$CTMX Market Capitalization: $410.61M
$CTMX Previous Close: $11.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEOGENOMICS INC
Industry: SERVICES-TESTING LABORATORIES [8734]
Position of ALISON L. HANNAH: Director
Holdings: 88,796 shares
Current Value: $713,920
Latest Transaction: Aug 10 2020
$NEO Market Capitalization: $625.74M
$NEO Previous Close: $8.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of ALISON L. HANNAH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 02 2021 | CTMX | CytomX Therapeutic ... | HANNAH ALISON L. | Chief Medical Offic ... | Option Exercise | A | 7.85 | 175,000 | 1,373,750 | 175,000 | |
| Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | M | 7.27 | 10,000 | 72,700 | 0 | |
| Aug 10 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Buy | M | 7.27 | 10,000 | 72,700 | 88,796 | 78.8 K to 88.8 K (+12.69 %) |
| Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Option Exercise | A | 28.54 | 3,448 | 98,406 | 3,448 | |
| Jun 01 2020 | NEO | NEOGENOMICS INC | HANNAH ALISON L. | Director | Grant | A | 0.00 | 2,698 | 0 | 78,796 | 76.1 K to 78.8 K (+3.55 %) |
| Feb 05 2020 | CTMX | CytomX Therapeutic ... | HANNAH ALISON L. | Chief Medical Offic ... | Option Exercise | A | 7.71 | 250,000 | 1,927,500 | 250,000 | |
| Feb 05 2020 | CTMX | CytomX Therapeutic ... | HANNAH ALISON L. | Chief Medical Offic ... | Option Exercise | A | 7.71 | 250,000 | 1,927,500 | 250,000 |